![Groundbreaking gene therapy treatment targeting sickle-cell disease and beta-thalassemia has been approved in the UK. Photo: The National](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/3DF4TB3ZDM7LJC62AQA4J57SE4.jpg?smart=true&auth=91fa6d249ac2003718db6989076e49c550622a6a63b5015ed5dd7c5acba80341&width=400&height=225)
Groundbreaking gene therapy treatment targeting sickle-cell disease and beta-thalassemia has been approved in the UK. Photo: The National
Groundbreaking gene therapy treatment targeting sickle-cell disease and beta-thalassemia has been approved in the UK. Photo: The National
Pioneering gene editing therapy for thalassemia approved for UK use
Casgevy is world’s first gene therapy targeting blood disorders using gene-clipping tool